Stocks · News reference

Henlius And Sandoz Enter Strategic Collaboration Covering Up To 10 Proposed Biosimilar Assets, Expanding Their 2025 Oncology Partnership

Aug 17, 2026, 5:25 AMBenzinga Newsdesk

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 17, 2026, 5:25 AM
Checked: Aug 17, 2026, 5:25 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 18, 2026, 10:23 AMBenzinga Newsdesk
Sandoz Partners With Fresenius Unit mAbxience On Licensing, Development, Manufacturing And Commercialization For An Emicizumab Biosimilar Candidate
Emicizumab biosimilar expands mAbxience's pipeline into haemophilia A and strengthens its presence in rare diseases.The agreement is consistent with mAbxience's strategy of broadening patient access to
FSNUY SDZNY
BenzingaJul 22, 2026, 4:27 PMBenzinga Newsdesk
Shares of generic drug companies are trading lower after President Trump announced that imported generics will be subject to a 100% import tariff following a two-year grace period in order to encourage reshoring of pharma manufacturing.
AMPH AMRX ANIP SDZNY TEVA